Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

1 treatments under study, led by Measles Vaccine

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT02943681Not ApplicableCompleted

A Second Dose of Measles Vaccine (MV) in the Second Year of Life

NCT02233127Completed

Birth Cohort in Rahimyar Khan, Pakistan

Showing all 2 trials

Research Network

Common Treatments

  • Measles Vaccine1

Active Sponsors

  • March of Dimes1
  • The Hospital for Sick Children1
  • Aga Khan University1
  • Bandim Health Project1

Top Investigators

Related Conditions

  • Child Mortality2
  • Child Development1
  • Child Behaviour1

Activity Timeline